‘AI speeding up drug design; next step is faster, cheaper medicines’: Siddhartha Mukherjee at HT Leadership Summit
He urged safeguards for faster trials and said India has a historic opportunity to make medicines faster, cheaper and better.
Oncologist and author Siddhartha Mukherjee, co-founder and CEO of Manas AI, addressed the 24th Hindustan Times Leadership Summit about the transformative potential of artificial intelligence in drug discovery. Mukherjee explained that AI has dramatically reduced the time required to design new medicines from years to months. However, he emphasized that AI must now make medicines faster, cheaper, and better for patients.
The most crucial aspect of AI's impact is its capacity to produce transformative medicines, particularly in the field of medicine. If this goal is not achieved, Mukherjee warned, it could create significant challenges for the future of AI across various industries. The challenging part of AI's role in drug discovery lies in the subsequent stages: testing the designed molecules in humans and obtaining regulatory approval, which remains largely unchanged.
Mukherjee highlighted India's significant opportunity to demonstrate the benefits of AI in drug testing and approval processes. He suggested that reforming the current system could help reverse a long-term trend of decreasing medicine approvals and increasing costs. Mukherjee's company, Manas AI, utilizes AI combined with "medicinal intelligence" to accelerate drug discovery, as demonstrated by the case of a pancreatic cancer drug that took only two hours to identify a target "keyhole" using AI, compared to ten years for a human researcher.
Despite these advancements, Mukherjee stressed that the back-end process of clinical trials remains largely unchanged and cautioned that AI should not compromise the reliability of medicines by allowing untested or less effective drugs to reach patients.
Written by urgent.news from Hindustan Times's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.